We believe a partnership is effective when goals are shared and partners are strategically aligned. Due to our unique organization, we specialize in providing partnering services that fit well with your goals and strategy, and we offer financial risk-sharing. We proudly call ourselves a Drug Development Organization as we engage actively in any phase of drug development; financially, scientifically and operationally.
Our dynamic research teams can make decisions swiftly, leverage cross-functional synergies and will quickly adapt to accommodate your current and future needs. The close collaboration between our biomarker research teams and clinical and regulatory experts helps ensure an unmatched level of support.
The first biochemical marker developed by Nordic Bioscience was serum osteocalcin, a marker of bone formation. This initial biomarker was followed by the development of a large spectrum of novel biomarkers in several different diseases.
We want to develop targeted treatments faster, better and cheaper with a more favorable risk-benefit ratio for patients and payers. We are a science driven organization that lives by three simple wordings: Sense of Urgency, Efficiency and Timely Care.
In Nordic Bioscience the Board of Directors consist of experienced and recognized personalities. The board ensures the company's prosperity by collectively directing the company's affairs, while meeting the appropriate interests of its shareholders and relevant stakeholders.
Our Scientific Leadership consist of experienced employees with many years of service in Nordic Bioscience auspices. The Scientific Leadership is together with the CEO directing the scientific efforts in their respective groups. Meet them here.
Please don't hesitate to contact us if you have any questions or other inquiries.